Jason P. Chan

Jason P. Chan

Auto-generated profile, based on publicly available information

Jason P. Chan

Department of Biology, Marian University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
JCJason P. Chan
Jason P. Chan
JCJoshua Cordeira
Joshua Cordeira
GCGerman A. Calderon
German A. Calderon
LILakshmanan K Iyer
Lakshmanan K Iyer
MRMaribel Rios
Maribel Rios

15 June 2014 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
HSHongying (Hoy) Shen
Hongying (Hoy) Shen
FGFrancesca Giordano
Francesca Giordano
YWYumei Wu
Yumei Wu
JCJason Chan
Jason Chan
CZChen Zhu
Chen Zhu
PCPietro De Camilli
Pietro De Camilli
Genetic studies have suggested a functional link between cholesterol/sphingolipid metabolism and endocytic membrane traffic. Here we show that perturbing the cholesterol/sphingomyelin balance in the plasma membrane results in the massive formation of clusters of narrow endocytic tubular invaginations positive for N-BAR proteins. These tubules are intensely positive for sphingosine kinase 1 (SPHK1). SPHK1 is also targeted to physiologically occurring early endocytic intermediates, and is highly enriched in nerve terminals, which are cellular compartments specialized for exo/endocytosis. Membrane recruitment of SPHK1 involves a direct, curvature-sensitive interaction with the lipid bilayer mediated by a hydrophobic patch on the enzyme’s surface. The knockdown of SPHKs results in endocytic recycling defects, and a mutation that disrupts the hydrophobic patch of Caenorhabditis elegans SPHK fails to rescue the neurotransmission defects in loss-of-function mutants of this enzyme. Our studies support a role for sphingosine phosphorylation in endocytic membrane trafficking beyond the established function of sphingosine-1-phosphate in intercellular signalling.

1 September 2006 in Neuroscience
Verified
Journal Article
Closed access
JCJ.P. Chan
J.P. Chan
TUT.J. Unger
T.J. Unger
JBJ. Byrnes
J. Byrnes
MRM. Rios
M. Rios

1 May 2013 in Current Biology
Verified
Journal Article
Closed access
HWHan Wang
Han Wang
KGKelly Girskis
Kelly Girskis
TJTom Janssen
Tom Janssen
JCJason P. Chan
Jason P. Chan
KDKrishnakali Dasgupta
Krishnakali Dasgupta
DSDerek Sieburth
Derek Sieburth

15 May 2012 in Genes & Development
Verified
Journal Article
Closed access
PDF file
JCJason P. Chan
Jason P. Chan
ZHZhitao Hu
Zhitao Hu
DSDerek Sieburth
Derek Sieburth
Sphingolipids are potent lipid second messengers that regulate cell differentiation, migration, survival, and secretion, and alterations in sphingolipid signaling have been implicated in a variety of diseases. However, how sphingolipid levels are regulated, particularly in the nervous system, remains poorly understood. Here, we show that the generation of sphingosine-1-phosphate by sphingosine kinase (SphK) promotes neurotransmitter release. Electrophysiological, imaging, and behavioral analyses ofCaenorhabditis elegansmutants lacking sphingosine kinasesphk-1indicate that neuronal development is normal, but there is a significant defect in neurotransmitter release from neuromuscular junctions. SPHK-1 localizes to discrete, nonvesicular regions within presynaptic terminals, and this localization is critical for synaptic function. Muscarinic agonists cause a rapid increase in presynaptic SPHK-1 abundance, whereas reduction of endogenous acetylcholine production results in a rapid decrease in presynaptic SPHK-1 abundance. Muscarinic regulation of presynaptic SPHK-1 abundance is mediated by a conserved presynaptic signaling pathway composed of the muscarinic acetylcholine receptor GAR-3, the heterotrimeric G protein Gαq, and its effector, Trio RhoGEF. SPHK-1 activity is required for the effects of muscarinic signaling on synaptic transmission. This study shows that SPHK-1 promotes neurotransmitter release in vivo and identifies a novel muscarinic pathway that regulates SphK abundance at presynaptic terminals.

28 August 2013 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
JCJason P. Chan
Jason P. Chan
TSTrisha A. Staab
Trisha A. Staab
HWHan Wang
Han Wang
CMChiara Mazzasette
Chiara Mazzasette
ZBZara Butte
Zara Butte
DSDerek Sieburth
Derek Sieburth
Acetylcholine (ACh) is a potent neuromodulator in the brain, and its effects on cognition and memory formation are largely performed through muscarinic acetylcholine receptors (mAChRs). mAChRs are often preferentially distributed on specialized membrane regions in neurons, but the significance of mAChR localization in modulating neuronal function is not known. Here we show that the Caenorhabditis elegans homolog of the M1/M3/M5 family of mAChRs, gar-3, is expressed in cholinergic motor neurons, and GAR-3-GFP fusion proteins localize to cell bodies where they are enriched at extrasynaptic regions that are in contact with the basal lamina. The GAR-3 N-terminal extracellular domain is necessary and sufficient for this asymmetric distribution, and mutation of a predicted N-linked glycosylation site within the N-terminus disrupts GAR-3-GFP localization. In transgenic animals expressing GAR-3 variants that are no longer asymmetrically localized, synaptic transmission at neuromuscular junctions is impaired and there is a reduction in the abundance of the presynaptic protein sphingosine kinase at release sites. Finally, GAR-3 can be activated by endogenously produced ACh released from neurons that do not directly contact cholinergic motor neurons. Together, our results suggest that humoral activation of asymmetrically localized mAChRs by ACh is an evolutionarily conserved mechanism by which ACh modulates neuronal function.